COVID-19: Anti-HIV drugs administered on Italian couple at Jaipur hospital

Image
ANI General News
Last Updated : Mar 10 2020 | 5:00 PM IST

In a first in India, doctors at SMS hospital in Jaipur have administrated the combination of anti-HIV drugs, lopinavir and ritonavir tablets, for the treatment of coronavirus on two Italian patients.

Earlier in February, ANI had reported that the India Council of Medical Research (ICMR) had sought an emergency approval from Central Drug Control Organisation (CDCSO) for restricted use of combination of the anti-HIV drugs for the treatment of COVID-19 patients in India.

Dr DS Meena, Medical Superintendent of SMS Hospital told ANI, "Following the all standard protocols and procedures by ICMR to have administered the combination of anti-HIV drugs - lopinavir and ritonavir tablets - for the treatment of COVID-19 patients. As of now, we have used this on Italian couple after taking their consent. Both of them are fine and stable."

"The female has tested negative now and her condition has improved while 69-year-old male is still positive and on non-invasive ventilation (NIV) support. As he is a chronic smoker this is creating a bit of problem for us," said a senior doctor, who is closely monitoring the health status of the Italian couple.

Previously in India, three medical students who returned to Kerala from China got contracted with the disease and confirmed positive with COVID-19. However, they recovered by symptomatic treatment without these anti-HIV combination tablets and were discharged from hospital.

Till date, the Union Health Ministry has confirmed about 45 positive cases of coronavirus patients across the country.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 10 2020 | 4:46 PM IST

Next Story